Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 14:14 (2126 d 19:27 ago) – Posting: # 18975
Views: 12,700

Dear all,

❝ You want to get either T1 or T2 approved.

T1 = R ∨ T2 = R: ⇒ 95% CI

In this case I argued for no adjustment (90% CI) in the past but nowadays I’m leaning towards an adjustment because which one will be marketed is part of a decision tree.


Isn't the common practice to first test T1 and T2 vs. R in a pilot study (and I will not get into a debate on whether alpha correction would be needed), select one of the two test formulations, and then test it in a pivotal study in the usual way ? How often do you see both test formulations directly tested in a pivotal study ?

OK, maybe if the product has a very low variability and the number of subjects remains very low, it could make sense and save time to directly go for the pivotal. Any experience ?
—
Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,665 registered users;
59 visitors (0 registered, 59 guests [including 5 identified bots]).
Forum time: 09:41 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5